Stocksigma LogoStocksigma Logo

Asston Pharmaceuticals Approves Auditor Appointment and Key Executive Remuneration Hikes

At its 7th Annual General Meeting on 29th Sep'26, Asston Pharmaceuticals Limited secured shareholder approval to adopt FY26 audited standalone financial

Asston Pharmaceuticals Approves Auditor Appointment and Key Executive Remuneration Hikes

Asston Pharmaceuticals Ltd 路 Change in Auditor 路 01 Oct 2026, 7:32 pm

Asston Pharmaceuticals Approves Auditor Appointment and Key Executive Remuneration Hikes At its 7th Annual General Meeting on 29th Sep'26, Asston Pharmaceuticals Limited secured shareholder approval to adopt FY26 audited standalone financial statements and re-appoint Managing Director Ashish Narayan Sakalkar, retiring by rotation. Members approved the appointment of M/s Panchal S K & Associates as Statutory Auditors. Additionally, shareholders sanctioned remuneration increases for Managing Director Ashish Narayan Sakalkar, Whole-time Director and CEO Saili Jayaram More, and Non-Executive Director Sachin Chandrakant Badakh.

Original exchange filing (PDF)

More announcements from Asston Pharmaceuticals Ltd

All Asston Pharmaceuticals Ltd announcements